DocSym
β
Searchsearch
Search
(C88.9) Malignant immunoproliferative disease, unspecified
More details coming soon
161 489 in individuals diagnosis malignant immunoproliferative disease, unspecified confirmed
32 609 deaths with diagnosis malignant immunoproliferative disease, unspecified
20% mortality rate associated with the disease malignant immunoproliferative disease, unspecified
Diagnosis malignant immunoproliferative disease, unspecified is diagnosed Men are 19.23% more likely than Women
96 270
Men receive the diagnosis malignant immunoproliferative disease, unspecified
20 804 (21.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
65 219
Women receive the diagnosis malignant immunoproliferative disease, unspecified
11 805 (18.1 %)Died from this diagnosis.
Risk Group for the Disease malignant immunoproliferative disease, unspecified - Men aged 60-64 and Women aged 75-79
In Men diagnosis is most often set at age 0-5, 15-19, 25-34, 40-94
Less common in men the disease occurs at Age 0-1, 5-14, 20-24, 35-39, 95+Less common in women the disease occurs at Age 0-5, 10-24, 35-39
In Women diagnosis is most often set at age 5-9, 25-34, 40-95+
Disease Features malignant immunoproliferative disease, unspecified
Absence or low individual and public risk
Malignant immunoproliferative disease, unspecified - what does this mean
Malignant immunoproliferative disease, unspecified is a type of cancer that occurs when white blood cells called lymphocytes, which are part of the body’s immune system, grow and divide abnormally. these cells can form tumors in the lymph nodes, spleen, and other organs, leading to a wide range of symptoms depending on the location of the tumors.
What happens during the disease - malignant immunoproliferative disease, unspecified
Malignant immunoproliferative disease, unspecified is caused by an abnormal proliferation of immune cells. this is due to a mutation in the genetic material of the cell, which causes the cell to produce an excessive amount of proteins that stimulate the immune system. this leads to an overactive immune response, resulting in the production of too many immune cells. these cells can then accumulate and form tumors, which can spread to other organs and cause further damage.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Blood tests to measure immune system activity
- Imaging scans such as X-rays, CT scans, and MRI scans
- Bone marrow biopsy
- Lymph node biopsy
- Tumor biopsy
- Flow cytometry to measure the number of white blood cells
- Genetic testing
Treatment and Medical Assistance
Main Goal of Treatment: To reduce the number of abnormal immune cells and provide symptom relief.
- Administer chemotherapy drugs to reduce the number of abnormal immune cells
- Prescribe medications to reduce inflammation
- Provide supportive care to manage symptoms and improve quality of life
- Suggest lifestyle modifications to reduce stress and improve overall health
- Refer to a specialist for further evaluation and treatment
- Monitor patient closely for any changes in symptoms or disease progression
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant immunoproliferative disease, unspecified - Prevention
Malignant immunoproliferative disease, unspecified can be prevented by maintaining a healthy lifestyle, avoiding exposure to toxins, and getting regular medical check-ups to detect any early signs of the disease. vaccines and other immunizations can also help reduce the risk of developing the disease.